aluates Reports

$ 0.0

Automative

Global New Chemical Entities (NCE) CDMO Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-36L18770

BUY CHAPTERS

Global New Chemical Entities (NCE) CDMO Market Research Report 2025

Code: QYRE-Auto-36L18770

Report

January 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Company

Companies

Neuland Laboratories Ltd.

Aspen API

Sai Life Sciences

Fermion

Syngene

Cerbios-Pharma SA

PharmaBlock Sciences (Nanjing), Inc.

KATSURA CHEMICAL CO., LTD

Regis Custom API

Dipharma Francis Srl (Dipharma)

Cohance

Suven Pharma

Aarti Pharmalabs Limited (APL)

New Chemical Entities (NCE) CDMO Market Size

The global market for New Chemical Entities (NCE) CDMO was valued at US$ 2614 million in the year 2024 and is projected to reach a revised size of US$ 5607 million by 2031, growing at a CAGR of 11.4% during the forecast period.

New Chemical Entities (NCE) CDMO Market

New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.

North American market for New Chemical Entities (NCE) CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for New Chemical Entities (NCE) CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for New Chemical Entities (NCE) CDMO in Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of New Chemical Entities (NCE) CDMO include KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for New Chemical Entities (NCE) CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Chemical Entities (NCE) CDMO.

The New Chemical Entities (NCE) CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global New Chemical Entities (NCE) CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the New Chemical Entities (NCE) CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of New Chemical Entities (NCE) CDMO Market Report

Report Metric	Details
Report Name	New Chemical Entities (NCE) CDMO Market
Accounted market size in year	US$ 2614 million
Forecasted market size in 2031	US$ 5607 million
CAGR	11.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Peptide NCE Oligonucleotide NCE Other
Segment by Application	Tumors Cardiovascular Diseases Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, Aarti Pharmalabs Limited (APL), Cerbios-Pharma SA, PharmaBlock Sciences Nanjing Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of New Chemical Entities (NCE) CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is New Chemical Entities (NCE) CDMO Market growing?

Ans: The New Chemical Entities (NCE) CDMO Market witnessing a CAGR of 11.4% during the forecast period 2025-2031.

What is the New Chemical Entities (NCE) CDMO Market size in 2031?

Ans: The New Chemical Entities (NCE) CDMO Market size in 2031 will be US$ 5607 million.

Who are the main players in the New Chemical Entities (NCE) CDMO Market report?

Ans: The main players in the New Chemical Entities (NCE) CDMO Market are KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, Aarti Pharmalabs Limited (APL), Cerbios-Pharma SA, PharmaBlock Sciences Nanjing Inc

What are the Application segmentation covered in the New Chemical Entities (NCE) CDMO Market report?

Ans: The Applications covered in the New Chemical Entities (NCE) CDMO Market report are Tumors, Cardiovascular Diseases, Other

What are the Type segmentation covered in the New Chemical Entities (NCE) CDMO Market report?

Ans: The Types covered in the New Chemical Entities (NCE) CDMO Market report are Peptide NCE, Oligonucleotide NCE, Other

Recommended Reports

CDMO Market Overview

Biologics & Specialty CDMO

Pharmaceutical Development Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Peptide NCE

1.2.3 Oligonucleotide NCE

1.2.4 Other

1.3 Market by Application

1.3.1 Global New Chemical Entities (NCE) CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Tumors

1.3.3 Cardiovascular Diseases

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global New Chemical Entities (NCE) CDMO Market Perspective (2020-2031)

2.2 Global New Chemical Entities (NCE) CDMO Growth Trends by Region

2.2.1 Global New Chemical Entities (NCE) CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 New Chemical Entities (NCE) CDMO Historic Market Size by Region (2020-2025)

2.2.3 New Chemical Entities (NCE) CDMO Forecasted Market Size by Region (2026-2031)

2.3 New Chemical Entities (NCE) CDMO Market Dynamics

2.3.1 New Chemical Entities (NCE) CDMO Industry Trends

2.3.2 New Chemical Entities (NCE) CDMO Market Drivers

2.3.3 New Chemical Entities (NCE) CDMO Market Challenges

2.3.4 New Chemical Entities (NCE) CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue

3.1.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue (2020-2025)

3.1.2 Global New Chemical Entities (NCE) CDMO Revenue Market Share by Players (2020-2025)

3.2 Global New Chemical Entities (NCE) CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by New Chemical Entities (NCE) CDMO Revenue

3.4 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio

3.4.1 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by New Chemical Entities (NCE) CDMO Revenue in 2024

3.5 Global Key Players of New Chemical Entities (NCE) CDMO Head office and Area Served

3.6 Global Key Players of New Chemical Entities (NCE) CDMO, Product and Application

3.7 Global Key Players of New Chemical Entities (NCE) CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 New Chemical Entities (NCE) CDMO Breakdown Data by Type

4.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Type (2020-2025)

4.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2026-2031)

5 New Chemical Entities (NCE) CDMO Breakdown Data by Application

5.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Application (2020-2025)

5.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America New Chemical Entities (NCE) CDMO Market Size (2020-2031)

6.2 North America New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)

6.4 North America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe New Chemical Entities (NCE) CDMO Market Size (2020-2031)

7.2 Europe New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)

7.4 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size (2020-2031)

8.2 Asia-Pacific New Chemical Entities (NCE) CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America New Chemical Entities (NCE) CDMO Market Size (2020-2031)

9.2 Latin America New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)

9.4 Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size (2020-2031)

10.2 Middle East & Africa New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 KATSURA CHEMICAL CO., LTD

11.1.1 KATSURA CHEMICAL CO., LTD Company Details

11.1.2 KATSURA CHEMICAL CO., LTD Business Overview

11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Introduction

11.1.4 KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.1.5 KATSURA CHEMICAL CO., LTD Recent Development

11.2 Regis Custom API

11.2.1 Regis Custom API Company Details

11.2.2 Regis Custom API Business Overview

11.2.3 Regis Custom API New Chemical Entities (NCE) CDMO Introduction

11.2.4 Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.2.5 Regis Custom API Recent Development

11.3 Neuland Laboratories Ltd.

11.3.1 Neuland Laboratories Ltd. Company Details

11.3.2 Neuland Laboratories Ltd. Business Overview

11.3.3 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Introduction

11.3.4 Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.3.5 Neuland Laboratories Ltd. Recent Development

11.4 Aspen API

11.4.1 Aspen API Company Details

11.4.2 Aspen API Business Overview

11.4.3 Aspen API New Chemical Entities (NCE) CDMO Introduction

11.4.4 Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.4.5 Aspen API Recent Development

11.5 Sai Life Sciences

11.5.1 Sai Life Sciences Company Details

11.5.2 Sai Life Sciences Business Overview

11.5.3 Sai Life Sciences New Chemical Entities (NCE) CDMO Introduction

11.5.4 Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.5.5 Sai Life Sciences Recent Development

11.6 Fermion

11.6.1 Fermion Company Details

11.6.2 Fermion Business Overview

11.6.3 Fermion New Chemical Entities (NCE) CDMO Introduction

11.6.4 Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.6.5 Fermion Recent Development

11.7 Dipharma Francis Srl (Dipharma)

11.7.1 Dipharma Francis Srl (Dipharma) Company Details

11.7.2 Dipharma Francis Srl (Dipharma) Business Overview

11.7.3 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Introduction

11.7.4 Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.7.5 Dipharma Francis Srl (Dipharma) Recent Development

11.8 Cohance

11.8.1 Cohance Company Details

11.8.2 Cohance Business Overview

11.8.3 Cohance New Chemical Entities (NCE) CDMO Introduction

11.8.4 Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.8.5 Cohance Recent Development

11.9 Suven Pharma

11.9.1 Suven Pharma Company Details

11.9.2 Suven Pharma Business Overview

11.9.3 Suven Pharma New Chemical Entities (NCE) CDMO Introduction

11.9.4 Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.9.5 Suven Pharma Recent Development

11.10 Syngene

11.10.1 Syngene Company Details

11.10.2 Syngene Business Overview

11.10.3 Syngene New Chemical Entities (NCE) CDMO Introduction

11.10.4 Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.10.5 Syngene Recent Development

11.11 Aarti Pharmalabs Limited (APL)

11.11.1 Aarti Pharmalabs Limited (APL) Company Details

11.11.2 Aarti Pharmalabs Limited (APL) Business Overview

11.11.3 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Introduction

11.11.4 Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.11.5 Aarti Pharmalabs Limited (APL) Recent Development

11.12 Cerbios-Pharma SA

11.12.1 Cerbios-Pharma SA Company Details

11.12.2 Cerbios-Pharma SA Business Overview

11.12.3 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Introduction

11.12.4 Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.12.5 Cerbios-Pharma SA Recent Development

11.13 PharmaBlock Sciences Nanjing Inc

11.13.1 PharmaBlock Sciences Nanjing Inc Company Details

11.13.2 PharmaBlock Sciences Nanjing Inc Business Overview

11.13.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Introduction

11.13.4 PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)

11.13.5 PharmaBlock Sciences Nanjing Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Company

Companies

Neuland Laboratories Ltd.

Aspen API

Sai Life Sciences

Fermion

Syngene

Cerbios-Pharma SA

PharmaBlock Sciences (Nanjing), Inc.

KATSURA CHEMICAL CO., LTD

Regis Custom API

Dipharma Francis Srl (Dipharma)

Cohance

Suven Pharma

Aarti Pharmalabs Limited (APL)

List of Tables

Table 1. Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Peptide NCE

Table 3. Key Players of Oligonucleotide NCE

Table 4. Key Players of Other

Table 5. Global New Chemical Entities (NCE) CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global New Chemical Entities (NCE) CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global New Chemical Entities (NCE) CDMO Market Share by Region (2020-2025)

Table 9. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global New Chemical Entities (NCE) CDMO Market Share by Region (2026-2031)

Table 11. New Chemical Entities (NCE) CDMO Market Trends

Table 12. New Chemical Entities (NCE) CDMO Market Drivers

Table 13. New Chemical Entities (NCE) CDMO Market Challenges

Table 14. New Chemical Entities (NCE) CDMO Market Restraints

Table 15. Global New Chemical Entities (NCE) CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global New Chemical Entities (NCE) CDMO Market Share by Players (2020-2025)

Table 17. Global Top New Chemical Entities (NCE) CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) CDMO as of 2024)

Table 18. Ranking of Global Top New Chemical Entities (NCE) CDMO Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by New Chemical Entities (NCE) CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of New Chemical Entities (NCE) CDMO, Headquarters and Area Served

Table 21. Global Key Players of New Chemical Entities (NCE) CDMO, Product and Application

Table 22. Global Key Players of New Chemical Entities (NCE) CDMO, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2020-2025)

Table 26. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2026-2031)

Table 28. Global New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2020-2025)

Table 30. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2026-2031)

Table 32. North America New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 47. KATSURA CHEMICAL CO., LTD Company Details

Table 48. KATSURA CHEMICAL CO., LTD Business Overview

Table 49. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product

Table 50. KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 51. KATSURA CHEMICAL CO., LTD Recent Development

Table 52. Regis Custom API Company Details

Table 53. Regis Custom API Business Overview

Table 54. Regis Custom API New Chemical Entities (NCE) CDMO Product

Table 55. Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 56. Regis Custom API Recent Development

Table 57. Neuland Laboratories Ltd. Company Details

Table 58. Neuland Laboratories Ltd. Business Overview

Table 59. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product

Table 60. Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 61. Neuland Laboratories Ltd. Recent Development

Table 62. Aspen API Company Details

Table 63. Aspen API Business Overview

Table 64. Aspen API New Chemical Entities (NCE) CDMO Product

Table 65. Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 66. Aspen API Recent Development

Table 67. Sai Life Sciences Company Details

Table 68. Sai Life Sciences Business Overview

Table 69. Sai Life Sciences New Chemical Entities (NCE) CDMO Product

Table 70. Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 71. Sai Life Sciences Recent Development

Table 72. Fermion Company Details

Table 73. Fermion Business Overview

Table 74. Fermion New Chemical Entities (NCE) CDMO Product

Table 75. Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 76. Fermion Recent Development

Table 77. Dipharma Francis Srl (Dipharma) Company Details

Table 78. Dipharma Francis Srl (Dipharma) Business Overview

Table 79. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product

Table 80. Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 81. Dipharma Francis Srl (Dipharma) Recent Development

Table 82. Cohance Company Details

Table 83. Cohance Business Overview

Table 84. Cohance New Chemical Entities (NCE) CDMO Product

Table 85. Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 86. Cohance Recent Development

Table 87. Suven Pharma Company Details

Table 88. Suven Pharma Business Overview

Table 89. Suven Pharma New Chemical Entities (NCE) CDMO Product

Table 90. Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 91. Suven Pharma Recent Development

Table 92. Syngene Company Details

Table 93. Syngene Business Overview

Table 94. Syngene New Chemical Entities (NCE) CDMO Product

Table 95. Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 96. Syngene Recent Development

Table 97. Aarti Pharmalabs Limited (APL) Company Details

Table 98. Aarti Pharmalabs Limited (APL) Business Overview

Table 99. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product

Table 100. Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 101. Aarti Pharmalabs Limited (APL) Recent Development

Table 102. Cerbios-Pharma SA Company Details

Table 103. Cerbios-Pharma SA Business Overview

Table 104. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product

Table 105. Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 106. Cerbios-Pharma SA Recent Development

Table 107. PharmaBlock Sciences Nanjing Inc Company Details

Table 108. PharmaBlock Sciences Nanjing Inc Business Overview

Table 109. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product

Table 110. PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)

Table 111. PharmaBlock Sciences Nanjing Inc Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. New Chemical Entities (NCE) CDMO Picture

Figure 2. Global New Chemical Entities (NCE) CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global New Chemical Entities (NCE) CDMO Market Share by Type: 2024 VS 2031

Figure 4. Peptide NCE Features

Figure 5. Oligonucleotide NCE Features

Figure 6. Other Features

Figure 7. Global New Chemical Entities (NCE) CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global New Chemical Entities (NCE) CDMO Market Share by Application: 2024 VS 2031

Figure 9. Tumors Case Studies

Figure 10. Cardiovascular Diseases Case Studies

Figure 11. Other Case Studies

Figure 12. New Chemical Entities (NCE) CDMO Report Years Considered

Figure 13. Global New Chemical Entities (NCE) CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global New Chemical Entities (NCE) CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global New Chemical Entities (NCE) CDMO Market Share by Region: 2024 VS 2031

Figure 16. Global New Chemical Entities (NCE) CDMO Market Share by Players in 2024

Figure 17. Global Top New Chemical Entities (NCE) CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) CDMO as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by New Chemical Entities (NCE) CDMO Revenue in 2024

Figure 19. North America New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)

Figure 21. United States New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)

Figure 25. Germany New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific New Chemical Entities (NCE) CDMO Market Share by Region (2020-2031)

Figure 33. China New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)

Figure 41. Mexico New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)

Figure 45. Turkey New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. KATSURA CHEMICAL CO., LTD Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 49. Regis Custom API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 50. Neuland Laboratories Ltd. Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 51. Aspen API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 52. Sai Life Sciences Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 53. Fermion Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 54. Dipharma Francis Srl (Dipharma) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 55. Cohance Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 56. Suven Pharma Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 57. Syngene Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 58. Aarti Pharmalabs Limited (APL) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 59. Cerbios-Pharma SA Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 60. PharmaBlock Sciences Nanjing Inc Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Chemical CDMO Market Research Report 2024

Global Large Molecule Drug Substance CDMO Market Research Report 2024

Global Small Molecules CDMO Services Market Research Report 2024

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Global Small Molecule Drug CDMO Services Market Research Report 2024

Global Full Service CDMO Market Research Report 2024

Global Contract Dose Manufacturing Market Insights Forecast to 2030

Global Pharmaceutical CDMO Market Research Report 2025

Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biological Drug CDMO Market Research Report 2024

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Formulation CDMO Services Market Research Report 2024

Global Peptide Drug CDMO Market Research Report 2024

Global New Chemical Entities NCE Market Research Report 2025

Global Microbiome CDMO Market Research Report 2024

Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Active Pharmaceutical Ingredients API CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Specialty Chemicals CDMO Service Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions